Joby Aviation Makes Massive $500 Million Defense Play. Here's What It Means For Investors.
Joby Aviation said Aug. 11 it will buy Resonant Sciences for about $500 million, including about $450 million in cash and $50 million in Joby stock. Resonant has over $100 million in trailing-12-month revenue and positive adjusted EBITDA. The deal would create a dedicated defense unit while Joby continues eVTOL air-taxi work, affecting liquidity and risk.
How this was made
The 30-second read
Why it matters
The acquisition of Resonant Sciences creates a dedicated defense business with trailing-12-month revenue over $100 million and positive adjusted EBITDA, but it reduces Joby liquidity to about $1.85 billion and shortens cash runway by an estimated 8 to 9 months based on the current burn rate.
Market read
A same-day M&A disclosure with explicit cash and stock consideration and a quantified liquidity/runway impact makes this a tradable catalyst for JOBY risk pricing.
What to watch
Investors may be underweighting deal execution risk (integration, customer transition) and the possibility that defense revenue growth timing lags the cash runway reduction.
Background
Joby is an eVTOL company pursuing FAA type certification and has been burning cash while seeking a sustainable commercial air taxi business.
Ticker impact
Joby announced it will acquire Resonant Sciences for about $500 million, including $450 million cash and $50 million in JOBY stock.
Near-term volatility likely as investors weigh diversification versus reduced cash runway; longer-term upside depends on defense growth and cross-technology benefits.
The article provides deal structure and cash impact (liquidity reduced to about $1.85B, shaving 8 to 9 months of runway) but does not provide deal timing, synergies, or integration milestones.
Market effects
Highlights a potential playbook for eVTOL firms to diversify via defense tech revenue while awaiting FAA certification.
Limited direct regional impact; defense customer base is U.S.-government oriented per the article.
Moderate, as defense tech demand and eVTOL certification timelines are global themes but the transaction is company-specific.
Counterpoint
The defense segment may not materially de-risk the core FAA certification and commercialization timeline, so the cash diversion could worsen dilution risk without near-term earnings support.
Key entities
- public_companyJoby Aviation
Subject of the article; announced a $500 million acquisition of Resonant Sciences to build a defense business.
- private_companyResonant Sciences
Defense technology company being acquired; over $100 million trailing-12-month revenue and positive adjusted EBITDA per the article.
- business_unitBlade Air Mobility
Source of much of Joby’s revenue base mentioned in the article, acquired in 2025.
- institutionMorgan Stanley
Cited for an eVTOL report that includes national security as an urban air mobility accelerant.
